Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelly Kalaora

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2018
Cancer Exome-Based Identification of Tumor Neo-Antigens Using Mass SpectrometryShelly Kalaora, Yardena Samuels
Nature Reviews. Cancer|February 2, 2022
Mechanisms of immune activation and regulation: lessons from melanomaShelly Kalaora, Adi Nagler, Jennifer A Wargo, et al.
Oncotarget|March 14, 2019
Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanomaMichal Alon, Rand Arafeh, Joo Sang Lee, et al.
Oncotarget|August 23, 2018
CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanomaMichal Alon, Rand Arafeh, Joo Sang Lee, et al.
Oncotarget|January 29, 2016
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigensShelly Kalaora, Eilon Barnea, Efrat Merhavi-Shoham, et al.
Pigment Cell & Melanoma Research|September 25, 2019
A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanomaAdi Nagler, David W Vredevoogd, Michal Alon, et al.
Nature Communications|February 16, 2020
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanomaShelly Kalaora, Joo Sang Lee, Eilon Barnea, et al.
Cell Reports|June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomicsAdi Nagler, Shelly Kalaora, Chaya Barbolin, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Neuronal activity triggers widespread changes in RNA stabilityErin E Duffy, Inés L Patop, Shelly Kalaora, et al.
Cancer Discovery|September 14, 2018
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yochai Wolf, Tali Feferman, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2018
Cancer Exome-Based Identification of Tumor Neo-Antigens Using Mass SpectrometryShelly Kalaora, Yardena Samuels
Nature Reviews. Cancer|February 2, 2022
Mechanisms of immune activation and regulation: lessons from melanomaShelly Kalaora, Adi Nagler, Jennifer A Wargo, et al.
Oncotarget|March 14, 2019
Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanomaMichal Alon, Rand Arafeh, Joo Sang Lee, et al.
Oncotarget|August 23, 2018
CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanomaMichal Alon, Rand Arafeh, Joo Sang Lee, et al.
Oncotarget|January 29, 2016
Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigensShelly Kalaora, Eilon Barnea, Efrat Merhavi-Shoham, et al.
Pigment Cell & Melanoma Research|September 25, 2019
A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanomaAdi Nagler, David W Vredevoogd, Michal Alon, et al.
Nature Communications|February 16, 2020
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanomaShelly Kalaora, Joo Sang Lee, Eilon Barnea, et al.
Cell Reports|June 24, 2021
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomicsAdi Nagler, Shelly Kalaora, Chaya Barbolin, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Neuronal activity triggers widespread changes in RNA stabilityErin E Duffy, Inés L Patop, Shelly Kalaora, et al.
Cancer Discovery|September 14, 2018
Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in MelanomaShelly Kalaora, Yochai Wolf, Tali Feferman, et al.
Pageof 2